Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Jensen

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvantR B Moss, E Webb, W K Giermakowska, et al.
AIDS (London, England)|November 1, 1993
Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatmentF Ferre, A L Marchese, S L Griffin, et al.
Cancer Research|September 1, 1983
Amplification of the murine leukemia virus Mr 70,000 glycoprotein gene product by human xenografts in athymic miceG M Beattie, R A Lannom, S M Baird, et al.
AIDS Research and Human Retroviruses|July 22, 1998
A primer on HIV type 1-specific immune function and REMUNER B Moss, W K Giermakowska, J R Savary, et al.
AIDS (London, England)|September 4, 1998
Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in ThailandV Churdboonchart, R B Moss, W Sirawaraporn, et al.
Clinical and Diagnostic Laboratory Immunology|May 30, 1998
In vitro p24 antigen-stimulated lymphocyte proliferation and beta-chemokine production in human immunodeficiency virus type 1 (HIV-1)-seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune)R B Moss, M R Wallace, P Lanza, et al.
Vaccine|May 1, 1998
Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccinationP Lanza, R B Moss, W Giermakowska, et al.
Blood|April 1, 1986
Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retrovirusesC C Sohn, D W Blayney, J L Misset, et al.
Viral Immunology|January 1, 1997
Cross-clade immune responses after immunization with a whole-killed gp120-depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE) in human immunodeficiency virus type-1 seropositive subjectsR B Moss, W Giermakowska, P Lanza, et al.
Journal of Human Virology|April 25, 2000
CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE)R B Moss, W K Giermakowska, J P Diveley, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes (1999)|September 2, 2000
HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvantR B Moss, E Webb, W K Giermakowska, et al.
AIDS (London, England)|November 1, 1993
Development and validation of a polymerase chain reaction method for the precise quantitation of HIV-1 DNA in blood cells from subjects undergoing a 1-year immunotherapeutic treatmentF Ferre, A L Marchese, S L Griffin, et al.
Cancer Research|September 1, 1983
Amplification of the murine leukemia virus Mr 70,000 glycoprotein gene product by human xenografts in athymic miceG M Beattie, R A Lannom, S M Baird, et al.
AIDS Research and Human Retroviruses|July 22, 1998
A primer on HIV type 1-specific immune function and REMUNER B Moss, W K Giermakowska, J R Savary, et al.
AIDS (London, England)|September 4, 1998
Effect of HIV-specific immune-based therapy in subjects infected with HIV-1 subtype E in ThailandV Churdboonchart, R B Moss, W Sirawaraporn, et al.
Clinical and Diagnostic Laboratory Immunology|May 30, 1998
In vitro p24 antigen-stimulated lymphocyte proliferation and beta-chemokine production in human immunodeficiency virus type 1 (HIV-1)-seropositive subjects after immunization with an inactivated gp120-depleted HIV-1 immunogen (Remune)R B Moss, M R Wallace, P Lanza, et al.
Vaccine|May 1, 1998
Whole-killed gp120-depleted HIV-1 antigen in a murine model for prophylactic vaccinationP Lanza, R B Moss, W Giermakowska, et al.
Blood|April 1, 1986
Leukopenic chronic T cell leukemia mimicking hairy cell leukemia: association with human retrovirusesC C Sohn, D W Blayney, J L Misset, et al.
Viral Immunology|January 1, 1997
Cross-clade immune responses after immunization with a whole-killed gp120-depleted human immunodeficiency virus type-1 immunogen in incomplete Freund's adjuvant (HIV-1 immunogen, REMUNE) in human immunodeficiency virus type-1 seropositive subjectsR B Moss, W Giermakowska, P Lanza, et al.
Journal of Human Virology|April 25, 2000
CXCR4 and CCR5 expression on CD4+ T cells in vivo and HIV-1 antigen beta-chemokine production in vitro after treatment with HIV-1 immunogen (REMUNE)R B Moss, W K Giermakowska, J P Diveley, et al.
Pageof 6